ADC Therapeutics (ADCT) Research & Development (2023 - 2026)
ADC Therapeutics' (ADCT) quarterly Research & Development came in at $19.9 million in Q1 2026, down 31.29% year-on-year from $28.9 million in Q1 2025, and down 25.84% quarter-over-quarter from $26.8 million in Q3 2025.
ADC Therapeutics (ADCT) Research & Development (2023 - 2026) Analysis & Trends
ADC Therapeutics has disclosed Research & Development across 4 years of filings, most recently posting $19.9 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -58.00 Mn |
| 10 | ADC Therapeutics | 167.24 Mn | -63.76 Mn | 7.33 Mn | 19.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.88 Mn |
| Sep 30, 2025 | 26.80 Mn |
| Jun 30, 2025 | 30.09 Mn |
| Mar 31, 2025 | 28.93 Mn |
| Sep 30, 2024 | 32.50 Mn |
| Jun 30, 2024 | 24.30 Mn |
| Mar 31, 2024 | 25.74 Mn |
| Sep 30, 2023 | 27.08 Mn |
| Jun 30, 2023 | 31.34 Mn |